Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.
Nucleoside hydrolases (NHs) show homology among parasite protozoa, fungi and bacteria. They are vital protagonists in the establishment of early infection and, therefore, are excellent candidates for the pathogen recognition by adaptive immune responses. Immune protection against NHs would prevent d...
Main Authors: | Dirlei Nico, Carla Claser, Gulnara P Borja-Cabrera, Luiz R Travassos, Marcos Palatnik, Irene da Silva Soares, Mauricio Martins Rodrigues, Clarisa B Palatnik-de-Sousa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC2976684?pdf=render |
Similar Items
-
Leishmania donovani Nucleoside Hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection
by: Dirlei eNico, et al.
Published: (2014-06-01) -
Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+-epitopes of Leishmania donovani Nucleoside Hydrolase terminal domains
by: Dirlei eNico, et al.
Published: (2014-05-01) -
Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines
by: Clarisa Beatriz Palatnik-de-Sousa, et al.
Published: (2019-04-01) -
The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice
by: Marcus Vinícius Alves-Silva, et al.
Published: (2019-04-01) -
F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis
by: Eugenia Carrillo, et al.
Published: (2017-07-01)